Pictet Asset Management (Switzerland)’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $2.73M | Sell |
1,270,132
-96,557
| -7% | -$208K | ﹤0.01% | 865 |
|
2023
Q1 | $2.67M | Buy |
1,366,689
+497,851
| +57% | +$971K | ﹤0.01% | 882 |
|
2022
Q4 | $3.34M | Sell |
868,838
-426,180
| -33% | -$1.64M | ﹤0.01% | 829 |
|
2022
Q3 | $6.24M | Hold |
1,295,018
| – | – | 0.01% | 676 |
|
2022
Q2 | $10.3M | Hold |
1,295,018
| – | – | 0.01% | 584 |
|
2022
Q1 | $19M | Sell |
1,295,018
-5,785
| -0.4% | -$85K | 0.02% | 508 |
|
2021
Q4 | $26.3M | Buy |
1,300,803
+188,902
| +17% | +$3.82M | 0.03% | 463 |
|
2021
Q3 | $30.2M | Buy |
+1,111,901
| New | +$30.2M | 0.03% | 427 |
|